Searchable abstracts of presentations at key conferences in endocrinology

ea0029p550 | Diabetes | ICEECE2012

Influence of iron metabolism indices on HbA1c in non-diabetic pregnant women with and without iron-deficiency anemia: effect of iron supplementation

Rafat D. , Rabbani T. , Ahmad J. , Ansari M.

Aims: Condition that influence erythrocyte turnover also affect HbA1c. Although many forms of anemia are associated with lowering of HbA1c, iron-deficiency anemia (IDA) tends to increase HbA1c. In this study, we examined the relationship between HbA1c and erythrocyte indices in non-diabetic pregnancy and assessed the effect of iron supplementation on HbA1c.Methods: 150 women were studied (30 non-diabetic, non-pregnant, non-anemic women in child bearing w...

ea0028p324 | Steroids | SFEBES2012

Ethanolic extract of Medicago sativa exhibits estrogen-like activity, increases serum total proteins and decreases serum total cholesterol contents in immature female rats

Ahmad Nazir , Akhtar Nafees , Rahman Zia , Ali Shujait

Medicago sativa plants are commonly used as green fodder. In this study, estrogen-like activity of ethanolic extract of Medicago sativa plants and its possible effects on serum biochemical metabolites in immature female rats were investigated. Crude extract of dried Medicago sativa plants was prepared in 90% ethanol using Soxhlet’s apparatus. Fifteen immature female rats were divided into 3 equal groups. Rats of groups A and B were given the extract at the dose of 250 (lo...

ea0025p128 | Diabetes, metabolism and cardiovascular | SFEBES2011

Safety profile of Vildagliptin in clinical practice: 2-year data from 2 Tertiary hospitals

Siddiqui Mohammad , Gupta Mukul , Wangnoo Subhash , Ahmad Jamal

Background and aims: Proper assessment of long-term safety of newer antidiabetic agents (ADAs) is of prime importance as diabetes is a chronic disease requiring life-long management. The purpose of this analysis was to assess the safety of vildagliptin as monotherapy or as an add-on therapy to already existing ADAs (vildagliptin group) compared to non-vildagliptin group.Materials and methods: Nine hundred and eighty-three patients in vildagliptin group a...

ea0022p198 | Clinical case reports and clinical practice | ECE2010

Administration of testosterone to elderly hypogonadal men with Crohn’s disease improves their Crohn’s disease activity index: a pilot study

Saad Farid , Haider Ahmad , Kurtz Winfred , Giltay Erik , Gooren Louis

Objectives: To investigate effects of testosterone in hypogonadal men with Crohn’s disease (CD).Design and methods: Thirteen men, aged 45–67 years were diagnosed with subnormal plasma testosterone. They received treatment with parenteral testosterone undecanoate. They also suffered from CD. The Crohn’s disease activity index (CDAI) (1) was used to assess the severity of the disease. Levels of testosterone and C-reactive protein (CRP) were ...

ea0021p6 | Bone | SFEBES2009

Bone mineral density in transitional endocrine clinic in a UK Teaching Hospital

Sreemantula Gayatri , Iqbal Cherakkattil , Didi Mohammed , Ahmad Aftab

Introduction: Endocrinopathies can cause secondary osteoporosis and little is known of the extent of this condition in young adults.Methods: In order to assess the bone health in endocrinopathies in young adults, a retrospective analysis of 25 transitional clinic patients who underwent dual energy X-ray absorptiometry (DEXA scan) was made using case notes and the hospital database.Results: Twenty-three patients were male and the me...

ea0020p152 | Thyroid | ECE2009

Comparing the Outcome of radioactive iodine treatment for hyperthyroidism in a Jordanian and British cohorts

Omari Ahmad , Haddad Fares , Malkawi Omar , Thaw Jonathan , Jennings Paul

Radioactive iodine (RAI) has been in use for more than 60 years with satisfactory results RAI and safe profile, there has been a different outcome of treatment in different ethnic groups. We assessed the demographic features and clinical outcome of a Jordanian and British cohorts of patients treated with RAI.Methods: Hyperthyroid patients who opted RAI as a primary therapy and those who had relapse after treatment with antithyroid drugs (ATD) or h...

ea0016p63 | Bone and calcium | ECE2008

Comparison of ultrasonography and 99mtechnetium sestamibi in localization of parathyroid adenoma in primary hyperparathyroidism

Nasiri Shirzad , Sourush Ahmad Reza , Hashemi Amir Pejman , Hedayat Anushiravan

Aims: Determine the utility of ultrasonography for the preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism and to compare this method with 99mtechnetium sestamibi scintigraphy.Methods: The results of ultrasonographic localization of enlarged parathyroid glands witch were performed by one experienced ultrasonographer were determined in 65 consecutive patients with primary hyperparathyroidism and compared with...

ea0016p560 | Obesity | ECE2008

Relationship of visceral adiposity with plasma adiponectin concentration: effect of weight loss

Nasseri Esmat , Hosseini Mostafa , Dorosti Ahmad Reza , Chamari Maryam

Objective: To investigate the associations between adiponectin levels and adiposity and body fat distribution indices assessed by waist to hip ratio in Iranian women and to determine if the association differ as a result of ethnicity.Methods: A cross-sectional study of 76 Iranian women free from metabolic disease was performed. Body mass index (BMI), waist circumferences, waist to hip ratio (WHR), body composition, insulin sensitivity, lipid profiles and...

ea0016p706 | Thyroid | ECE2008

Assessment of cobalt status: a comparison between goiterous children and healthy control subjects

Sanjari Mojgan , Gholamhosseinian Ahmad , Nakhaee Nouzar , Mashrooteh Mahdieh

Introduction: Cobalt is a relatively rare magnetic element with properties similar to iron and nickel. Cobalt is an essential element necessary for the formation of vitamin B12; however, excessive administration of this trace element produces goiter and reduced thyroid activity. This study was done to compare the prevalence of cobalt excess (as a cause of goiter) between goiterous and non goiterous children and to assay the relationship between serum cobalt and thyroid hormone...

ea0013p11 | Bone | SFEBES2007

Alendronate accelerates increases in bone mineral density with growth hormone replacement but may attenuate the anabolic effect of growth gormone replacement on bone in adult growth hormone deficiency

White Helen , Ahmad Aftab , Durham Brian , Fraser William , Vora Jiten

Introduction: Adult Growth Hormone Deficiency (AGHD) is associated with osteoporosis. Underlying mechanisms involved in the pathogenesis include reduced target-organ sensitivity to the effect of PTH. Growth Hormone Replacement (GHR) in AGHD leads to increased PTH target-organ sensitivity and consequently increased bone turnover and bone mineral density (BMD).Aims: We determined the effect of alendronate, given in addition to GHR, on PTH target-organ sens...